{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:30:52Z","timestamp":1757622652851,"version":"3.44.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"kashan university","award":["99255"],"award-info":[{"award-number":["99255"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04376-w","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:54:59Z","timestamp":1754499299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulatory effect of CD71+ erythroid cells in patients with kidney failure"],"prefix":"10.1186","volume":"26","author":[{"given":"Batool","family":"Zamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Riazian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud Moeini","family":"Taba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Namdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fateme Zareei","family":"Barzoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolamir","family":"Atapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Motedayyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"4376_CR1","doi-asserted-by":"publisher","first-page":"205873841986323","DOI":"10.1177\/2058738419863238","volume":"33","author":"F Fathi","year":"2019","unstructured":"Fathi F, Atapour A, Eskandari N, Keyhanmehr N, Hafezi H, Mohammadi S, et al. Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus. Int J ImmunoPathol Pharmacol. 2019;33:2058738419863238.","journal-title":"Int J ImmunoPathol Pharmacol"},{"key":"4376_CR2","unstructured":"Abbasi MA, Chertow GM, Hall YN. End-stage renal disease. BMJ clinical evidence. 2010;2010."},{"issue":"02","key":"4376_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5482\/HAMO-14-11-0063","volume":"36","author":"A Bauer","year":"2016","unstructured":"Bauer A, Limperger V, Nowak-G\u00f6ttl U. End-stage renal disease and thrombophilia. H\u00e4mostaseologie. 2016;36(02):103\u20137.","journal-title":"H\u00e4mostaseologie"},{"issue":"2","key":"4376_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/01.aoa.0000463818.02019.99","volume":"35","author":"C Wu","year":"2015","unstructured":"Wu C, Chen S, Ho C, Liang F, Chu C, Wang H, et al. End-stage renal disease after hypertensive disorders in pregnancy. Obstetric Anesth Digest. 2015;35(2):74.","journal-title":"Obstetric Anesth Digest"},{"issue":"5","key":"4376_CR5","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrology: CJASN. 2008;3(5):1526\u201333.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"4376_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000479254","volume":"191","author":"L Dai","year":"2017","unstructured":"Dai L, Golembiewska E, Lindholm B, Stenvinkel P. End-Stage renal disease, inflammation and cardiovascular outcomes. Contrib Nephrol. 2017;191:32\u201343.","journal-title":"Contrib Nephrol"},{"key":"4376_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fimmu.2014.00376","volume":"5","author":"S Elahi","year":"2014","unstructured":"Elahi S. New insight into an old concept: role of immature erythroid cells in immune pathogenesis of neonatal infection. Front Immunol. 2014;5:376.","journal-title":"Front Immunol"},{"key":"4376_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1297-9716-42-89","volume":"42","author":"D Morera","year":"2011","unstructured":"Morera D, MacKenzie SA. Is there a direct role for erythrocytes in the immune response? Vet Res. 2011;42:89.","journal-title":"Vet Res"},{"key":"4376_CR9","doi-asserted-by":"publisher","first-page":"107927","DOI":"10.1016\/j.pharmthera.2021.107927","volume":"228","author":"TM Grzywa","year":"2021","unstructured":"Grzywa TM, Nowis D, Golab J. The role of CD71\u2009+\u2009erythroid cells in the regulation of the immune response. Pharmacol Ther. 2021;228:107927.","journal-title":"Pharmacol Ther"},{"issue":"7478","key":"4376_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nature12675","volume":"504","author":"S Elahi","year":"2013","unstructured":"Elahi S, Ertelt JM, Kinder JM, Jiang TT, Zhang X, Xin L, et al. Immunosuppressive CD71\u2009+\u2009erythroid cells compromise neonatal host defence against infection. Nature. 2013;504(7478):158\u201362.","journal-title":"Nature"},{"key":"4376_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1749-6632.1991.tb17276.x","volume":"628","author":"AV Mitasov","year":"1991","unstructured":"Mitasov AV, Tsyrlova IG, Kiselev SV, Kozlov VV. Species-nonspecific action of soluble immunosuppressive factor produced by murine immature erythroid cells. Ann N Y Acad Sci. 1991;628:399\u2013409.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"4376_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1182\/blood.V93.3.796","volume":"93","author":"R De Maria","year":"1999","unstructured":"De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, et al. Apoptotic role of fas\/fas ligand system in the regulation of erythropoiesis. Blood. 1999;93(3):796\u2013803.","journal-title":"Blood"},{"issue":"1","key":"4376_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2121-5-39","volume":"5","author":"SV Sennikov","year":"2004","unstructured":"Sennikov SV, Injelevskaya TV, Krysov SV, Silkov AN, Kovinev IB, Dyachkova NJ, et al. Production of hemo- and immunoregulatory cytokines by erythroblast antigen\u2009+\u2009and Glycophorin A\u2009+\u2009cells from human bone marrow. BMC Cell Biol. 2004;5(1):39.","journal-title":"BMC Cell Biol"},{"issue":"7478","key":"4376_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nature12675","volume":"504","author":"S Elahi","year":"2013","unstructured":"Elahi S, Ertelt JM, Kinder JM, Jiang TT, Zhang X, Xin L, et al. Immunosuppressive CD71\u2009+\u2009erythroid cells compromise neonatal host defence against infection. Nature. 2013;504(7478):158.","journal-title":"Nature"},{"issue":"1","key":"4376_CR15","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1038\/s41598-017-07938-7","volume":"7","author":"A Namdar","year":"2017","unstructured":"Namdar A, Koleva P, Shahbaz S, Strom S, Gerdts V, Elahi S. CD71\u2009+\u2009erythroid suppressor cells impair adaptive immunity against Bordetella pertussis. Sci Rep. 2017;7(1):7728.","journal-title":"Sci Rep"},{"issue":"6","key":"4376_CR16","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.4049\/jimmunol.1700742","volume":"199","author":"G Dunsmore","year":"2017","unstructured":"Dunsmore G, Bozorgmehr N, Delyea C, Koleva P, Namdar A, Elahi S. Erythroid suppressor cells compromise neonatal immune response against Bordetella pertussis. J Immunol. 2017;199(6):2081\u201395.","journal-title":"J Immunol"},{"issue":"2","key":"4376_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ecco-jcc\/jjy147","volume":"13","author":"G Dunsmore","year":"2019","unstructured":"Dunsmore G, Koleva P, Ghobakhloo N, Sutton R, Ambrosio L, Meng X, et al. Lower abundance and impaired function of CD71\u2009+\u2009Erythroid cells in inflammatory bowel disease patients during pregnancy. J Crohn\u2019s Colitis. 2019;13(2):230\u201344.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"4","key":"4376_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/JLB.5A0717-291RRR","volume":"103","author":"D Miller","year":"2018","unstructured":"Miller D, Romero R, Unkel R, Xu Y, Vadillo-Ortega F, Hassan SS, et al. CD71\u2009+\u2009erythroid cells from neonates born to women with preterm labor regulate cytokine and cellular responses. J Leukoc Biol. 2018;103(4):761\u201375.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"4376_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/aji.12556","volume":"76","author":"N Gomez-Lopez","year":"2016","unstructured":"Gomez-Lopez N, Romero R, Xu Y, Miller D, Unkel R, CM T, et al. Umbilical cord CD71\u2009+\u2009erythroid cells are reduced in neonates born to women in spontaneous preterm labor. Am J Reproductive Immunol (New York NY: 1989). 2016;76(4):280\u20134.","journal-title":"Am J Reproductive Immunol (New York NY: 1989)"},{"key":"4376_CR20","doi-asserted-by":"crossref","unstructured":"Sedaghat N, MOTEDAYYEN H, Alsahebfosoul F, Etemadifar M, Ostadi V, Kianpour F et al. Increased expression of lymphocyte activation Gene-3 by regulatory T cells in multiple sclerosis patients with Fingolimod treatment. Turkish J Immunol. 2019;7(1).","DOI":"10.25002\/tji.2019.1035"},{"issue":"5","key":"4376_CR21","first-page":"1032","volume":"1","author":"NMH Sedaghat","year":"2018","unstructured":"Sedaghat NMH, Etemadifar M, Zarkesh H, Kianpour F, Vestri E, et al. Effect of Fingolimod on the frequency of regulatory T cells in patients with Relapsing-Remitting multiple sclerosis. J Immune Res. 2018;1(5):1032.","journal-title":"J Immune Res"},{"issue":"4","key":"4376_CR22","first-page":"243","volume":"47","author":"HM Zahra Adnani Sadati","year":"2018","unstructured":"Zahra Adnani Sadati HM, Sherkat R, Nahid Eskandari. Comparison of the percentage of regulatory T cells and their p-STAT5 expression in allergic and Non-Allergic common variable immunodeficiency patients. Immnological Investigations. 2018;47(4):243\u201356.","journal-title":"Immnological Investigations"},{"issue":"5","key":"4376_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/08820139.2019.1571506","volume":"48","author":"N Keyhanmehr","year":"2019","unstructured":"Keyhanmehr N, Motedayyen H, Eskandari N. The effects of Silymarin and cyclosporine A on the proliferation and cytokine production of regulatory T cells. Immunol Invest. 2019;48(5):533\u201348.","journal-title":"Immunol Invest"},{"key":"4376_CR24","doi-asserted-by":"publisher","first-page":"155439","DOI":"10.1016\/j.cyto.2021.155439","volume":"140","author":"R Sami","year":"2021","unstructured":"Sami R, Fathi F, Eskandari N, Ahmadi M, ArefNezhad R, Motedayyen H. Characterizing the immune responses of those who survived or succumbed to COVID-19: can immunological signatures predict outcome? Cytokine. 2021;140:155439.","journal-title":"Cytokine"},{"issue":"5\u20136","key":"4376_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/08820130701790368","volume":"36","author":"TM Brusko","year":"2007","unstructured":"Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA. Assessing the in vitro suppressive capacity of regulatory T cells. Immunol Investig. 2007;36(5\u20136):607\u201328.","journal-title":"Immunol Investig"},{"key":"4376_CR26","doi-asserted-by":"publisher","first-page":"205873842096649","DOI":"10.1177\/2058738420966497","volume":"34","author":"F Fathi","year":"2020","unstructured":"Fathi F, Sami R, Mozafarpoor S, Hafezi H, Motedayyen H, Arefnezhad R, et al. Immune system changes during COVID-19 recovery play key role in determining disease severity. Int J ImmunoPathol Pharmacol. 2020;34:2058738420966497.","journal-title":"Int J ImmunoPathol Pharmacol"},{"key":"4376_CR27","doi-asserted-by":"crossref","unstructured":"Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR et al. Direct demonstration of cytokine synthesis heterogeneity among human memory\/effector T cells by flow cytometry. 1995.","DOI":"10.1182\/blood.V86.4.1408.bloodjournal8641408"},{"issue":"1","key":"4376_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/0471142735.im0624s110","volume":"110","author":"Y Yin","year":"2015","unstructured":"Yin Y, Mitson-Salazar A, Prussin C. Detection of intracellular cytokines by flow cytometry. Curr Protocols Immunol. 2015;110(1):6. 1\u20136. 18.","journal-title":"Curr Protocols Immunol"},{"issue":"1\u20132","key":"4376_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0022-1759(96)00089-0","volume":"195","author":"J Ridings","year":"1996","unstructured":"Ridings J, Weedon H, Ioannou C, Flego L, Macardle P, Zola H. Purification of cord blood lymphocytes. J Immunol Methods. 1996;195(1\u20132):43\u20138.","journal-title":"J Immunol Methods"},{"issue":"1","key":"4376_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/0471142735.im0701s85","volume":"85","author":"IJ Fuss","year":"2009","unstructured":"Fuss IJ, Kanof ME, Smith PD, Zola H. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protocols Immunol. 2009;85(1):7. -7.1. 8.","journal-title":"Curr Protocols Immunol"},{"issue":"5","key":"4376_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrneph.2013.44","volume":"9","author":"MG Betjes","year":"2013","unstructured":"Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9(5):255.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4376_CR32","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4376_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4049\/jimmunol.1500771","volume":"195","author":"JL Wynn","year":"2015","unstructured":"Wynn JL, Scumpia PO, Stocks BT, Romano-Keeler J, Alrifai MW, Liu J-H, et al. Neonatal CD71\u2009+\u2009erythroid cells do not modify murine sepsis mortality. J Immunol. 2015;195(3):1064\u201370.","journal-title":"J Immunol"},{"issue":"2","key":"4376_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.pcl.2012.12.003","volume":"60","author":"A Camacho-Gonzalez","year":"2013","unstructured":"Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60(2):367.","journal-title":"Pediatr Clin North Am"},{"issue":"12","key":"4376_CR35","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.4049\/jimmunol.1800113","volume":"200","author":"C Delyea","year":"2018","unstructured":"Delyea C, Bozorgmehr N, Koleva P, Dunsmore G, Shahbaz S, Huang V, et al. CD71\u2009+\u2009erythroid suppressor cells promote fetomaternal tolerance through arginase-2 and PDL-1. J Immunol. 2018;200(12):4044\u201358.","journal-title":"J Immunol"},{"issue":"6","key":"4376_CR36","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/ndt\/gfp005","volume":"24","author":"TK Hendrikx","year":"2009","unstructured":"Hendrikx TK, van Gurp EA, Mol WM, Schoordijk W, Sewgobind VD, IJzermans JN, et al. End-stage renal failure and regulatory activities of CD4\u2009+\u2009CD25bright\u2009+\u2009FoxP3\u2009+\u2009T-cells. Nephrol Dialysis Transplantation. 2009;24(6):1969\u201378.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"1","key":"4376_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1681\/ASN.2006050514","volume":"18","author":"P Meier","year":"2007","unstructured":"Meier P, Blanc E, Burnier M. Oxidized low-density lipoproteins activate CD4\u2009+\u2009T cell apoptosis in patients with end-stage renal disease through Fas engagement. J Am Soc Nephrol. 2007;18(1):331\u201342.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"4376_CR38","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/ndt\/gfi048","volume":"20","author":"M Ando","year":"2005","unstructured":"Ando M, Shibuya A, Yasuda M, Azuma N, Tsuchiya K, Akiba T, et al. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal Dialysis. Nephrol Dialysis Transplantation. 2005;20(11):2497\u2013503.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"8","key":"4376_CR39","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/ndt\/15.8.1217","volume":"15","author":"U Sester","year":"2000","unstructured":"Sester U, Sester M, Hauk M, Kaul H, K\u00f6hler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dialysis Transplantation. 2000;15(8):1217\u201323.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"2","key":"4376_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.imlet.2011.10.002","volume":"141","author":"BH Chung","year":"2012","unstructured":"Chung BH, Kim KW, Sun IO, Choi SR, Park HS, Jeon EJ, et al. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett. 2012;141(2):181\u20139.","journal-title":"Immunol Lett"},{"issue":"8","key":"4376_CR41","doi-asserted-by":"publisher","first-page":"e73141","DOI":"10.1371\/journal.pone.0073141","volume":"8","author":"L Mansouri","year":"2013","unstructured":"Mansouri L, Paulsson JM, Moshfegh A, Jacobson SH, Lundahl J. Leukocyte proliferation and immune modulator production in patients with chronic kidney disease. PLoS ONE. 2013;8(8):e73141.","journal-title":"PLoS ONE"},{"issue":"10","key":"4376_CR42","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/ndt\/gfg330","volume":"18","author":"K Anding","year":"2003","unstructured":"Anding K, Gross P, Rost JM, Allgaier D, Jacobs E. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dialysis Transplantation. 2003;18(10):2067\u201373.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"12","key":"4376_CR43","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/ndt\/gfg441","volume":"18","author":"E Majewska","year":"2003","unstructured":"Majewska E, Baj Z, Sulowska Z, Rysz J, Luciak M. Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol Dialysis Transplantation. 2003;18(12):2582\u20138.","journal-title":"Nephrol Dialysis Transplantation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04376-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04376-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04376-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T22:05:47Z","timestamp":1757369147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04376-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4376"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04376-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experimental protocols were approved by the Ethics Committee of Kashan University of Medical Sciences (ethic code: IR.KAUMS.MEDNT.REC.1400.030) and performed according to the declaration of Helsinki. Participants gave informed consent before entering the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}